We are excited to kick off the new year by announcing the launch of the new MIT Center for Precision Cancer Medicine, housed within the KI and established by a major gift from an anonymous donor. With Director Michael Yaffe at the helm, the Center will advance progress within the field of precision medicine — one of the KI's five research focus areas. Fellow faculty members Michael Hemann, Angela Koehler, Matthew Vander Heiden, and Forest White join this endeavor. Driven by internal and external collaborations, particularly with clinical partners, the Center will focus on identifying the most effective drugs and combinations for individual patients.